cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.36+0.00 (+0.28%)
Close on Nov 17, 2026Market cap $4.08MP/E –Yield –
cbdMD EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
cbdMD's EPS for the twelve months ending Jun 30, 2023 was -$143.78. For fiscal 2025 it was -$1.09. The highest annual figure on record is $100.80 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$1.09 | – |
| FY2024 | Sep 30, 2024 | -$14.29 | – |
| FY2023 | Sep 30, 2023 | -$106.56 | – |
| FY2022 | Sep 30, 2022 | -$446.40 | – |
| FY2021 | Sep 30, 2021 | -$169.20 | -267.9% |
| FY2020 | Sep 30, 2020 | $100.80 | – |
| FY2019 | Sep 30, 2019 | $0.00 | – |
| FY2018 | Sep 30, 2018 | $0.00 | – |
| FY2017 | Sep 30, 2017 | -$136.80 | – |
| FY2016 | Sep 30, 2016 | -$406.80 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$0.11 | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$0.08 | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$0.04 | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$0.21 | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$1.90 | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$1.73 | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$1.20 | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$10.80 | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$9.28 | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$13.92 | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$28.80 | -500.0% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$91.78 | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$198.48 | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$27.31 | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $7.20 | -95.0% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$86.40 | -153.3% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$64.80 | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $0.00 | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $144.00 | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $162.00 | +1400.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $0.00 | -100.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $0.00 | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $0.00 | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $10.80 | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $61.20 | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$57.60 | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$21.32 | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $0.00 | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$46.80 | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$64.80 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?